ArticleInternational journal of molecular sciences2026
HistoMap: Reconstructing Spatially Resolved Single-Cell Profiles from Bulk RNA-Seq to Decipher the Immune-Excluded Microenvironment in Colon Cancer.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Bulk RNA-sequencing (bulk RNA-seq) averages gene expression across cell mixtures, obscuring single-cell heterogeneity and spatial architectures essential for understanding pathological processes. We developed HistoMap, a deep learning-based framework for single-cell spatial deconvolution. The model employs a two-stage pipeline: first, reconstructing high-fidelity single-cell profiles from bulk data using a β-variational autoencoder, and second, utilizing a Histological Vision Transformer (H-ViT) to map these cells to tissue coordinates via dual guidance from transcriptomic references and H&E-stained morphological constraints. HistoMap demonstrated superior performance across diverse human tissues, achieving a Pearson Correlation Coefficient (PCC) of 0.800 on external validation. Application to 14 colorectal cancer cases revealed a Macro_SPP1-mediated desmoplastic barrier. SPP1+ macrophages act as spatial hubs at the invasive front, forming a physical "sequestration belt" that functionally excludes cytotoxic T cells from the tumor core. HistoMap successfully bridges bulk RNA-seq and spatial single-cell architectures. Our findings provide a molecular rationale for immune checkpoint blockade resistance and identify the SPP1-fibroblast axis as a pivotal target for therapeutic sensitization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.